![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India
US pharmaceutical giant Gilead Sciences is likely to apply to India's Central Drugs Standard Control Organisation (CDSCO) soon seeking marketing authorisation for its anti-viral...
Clinical Trials
Pfizer reports gene therapy data from Phase Ib DMD trial
Pfizer has reported new data from the Phase Ib clinical trial of PF-06939926 for the treatment of patients with Duchenne muscular dystrophy (DMD).
PF-06939926 is...
Clinical Trials
Abivax gets approval to conduct Covid-19 trial in France
Biotechnology company Abivax has secured approval from France’s National Agency for the Safety of Medicines (ANSM) and French Ethics Committee (CPP) to conduct a...
Clinical Trials
Vibalogics announces collaboration to provide additional clinical trial material for covid-19 vaccine candidate
Vibalogics, a global contract development and manufacturing organization (CDMO) that specializes in the production of virotherapy products, announced that it will manufacture additional clinical...
Clinical Trials
Greenphire Enhances Its Participant Payment and Reimbursement Solution to Further Support Remote Clinical Trials
As the COVID-19 pandemic continues to limit movement all over the world, clinical trials have had to adapt by leveraging methodologies typically associated with...
Clinical Trials
Humanigen Initiates Phase III Lenzilumab Study in COVID-19
Humanigen, Inc., has dosed the first COVID-19 patient in its Phase III study for lenzilumab, its Humaneered anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal...
Clinical Trials
Bioclinica Launches COVID-19 Clinical Endpoint Adjudication Solution
Bioclinica has introduced a specialized program for the adjudication of adverse events that could result from COVID-19 infection. Bioclinica's new program provides an out-of-the-box...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read